Streptomycin ELISA Kit (ab285226)
Key features and details
- Sensitivity: 0.1 ng/ml
- Range: 0.1 ng/ml - 8.1 ng/ml
- Sample type: Milk, Tissue
- Detection method: Colorimetric
- Assay type: Competitive
Overview
-
Product name
Streptomycin ELISA Kit -
Detection method
Colorimetric -
Sample type
Milk, Tissue -
Assay type
Competitive -
Sensitivity
< 0.1 ng/ml -
Range
0.1 ng/ml - 8.1 ng/ml -
Assay duration
Multiple steps standard assay -
Product overview
Streptomycin is an antibiotic (antimycobacterial) drug, the first of a class of drugs called aminoglycosides to be discovered, and it was the first effective treatment for tuberculosis. It is derived from the actinobacterium Streptomyces griseus. Streptomycin is a bactericidal antibiotic. Adverse effects of this medicine are ototoxicity, nephrotoxicity, fetal auditory toxicity, and neuromuscular paralysis.
This Streptomycin ELISA kit (ab285226, E4272) is a competitive ELISA assay for the quantitative measurement of Streptomycin in tissue, honey and milk. The density of color is proportional to the amount of Streptomycin captured from the samples.
-
Notes
This product is manufactured by BioVision, an Abcam company and was previously called E4272 Streptomycin ELISA Kit. E4272-100 is the same size as the 96 test size of ab285226.
-
Platform
Microplate (12 x 8 well strips)
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 96 tests 20X Concentrated Wash Solution 1 x 40ml 5X Concentrated Redissolving solution 1 x 50ml Antibody working solution 1 x 5.5ml Enzyme conjugate 1 x 11ml High standard (1000 ppb) 1 x 1ml Micro ELISA Plate 1 unit Plate Sealer 1 unit Standard 1 (0 ppb) 1 x 1ml Standard 2 (0.1 ppb) 1 x 1ml Standard 3 (0.3 ppb) 1 x 1ml Standard 4 (0.9 ppb) 1 x 1ml Standard 5 (2.7 ppb) 1 x 1ml Standard 6 (8.1 ppb) 1 x 1ml Stop Solution 1 x 6ml Substrate A solution 1 x 6ml Substrate B solution 1 x 6ml -
Research areas
-
Relevance
Streptomycin is an antibiotic produced by soil bacteria of the genus Streptomyces and is active against both gram positive and gram negative bacteria, including species resistant to other antibiotics, eg some streptococci, penicillin resistant staphylococci, and bacteria of the genera Proteus and Pseudomonas. Originally isolated by Selman A. Waksman and Albert Schatz in 1947, streptomycin is effective against tubercle bacilli and is a mainstay of tuberculosis therapy. Because streptomycin resistant tubercle bacilli emerge during treatment, the antibiotic is usually used in combination with one or more of the drugs isoniazid, ethambutol, and aminosalicylic acid. Streptomycin acts by inhibiting protein synthesis and damaging cell membranes in susceptible microorganisms. Possible side effects include injury to the kidneys and nerve damage that can result in dizziness and deafness.
Images
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab285226 has not yet been referenced specifically in any publications.